Experimental NIH Malaria Monoclonal Antibody Protective in Malian Children
April 28, 2024
April 28, 2024
WASHINGTON, April 28 (TNSres) -- The U.S. Department of Health and Human Services' National Institutes of Health issued the following news release on April 26, 2024:
* * *
Mid-stage trial shows treatment prevents infection, disease.
* * *
One injected dose of an experimental malaria monoclonal antibody was 77% effective against malaria disease in children in Mali during the country's six-month malaria season, according to the results . . .
* * *
Mid-stage trial shows treatment prevents infection, disease.
* * *
One injected dose of an experimental malaria monoclonal antibody was 77% effective against malaria disease in children in Mali during the country's six-month malaria season, according to the results . . .